Eintrag weiter verarbeiten
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
Gespeichert in:
| Zeitschriftentitel: | Blood |
|---|---|
| Personen und Körperschaften: | , , , , , , , , , , |
| In: | Blood, 125, 2015, 13, S. 2062-2067 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Hematology
|
| Schlagwörter: |
| author_facet |
Jain, Preetesh Keating, Michael Wierda, William Estrov, Zeev Ferrajoli, Alessandra Jain, Nitin George, Binsah James, Danelle Kantarjian, Hagop Burger, Jan O’Brien, Susan Jain, Preetesh Keating, Michael Wierda, William Estrov, Zeev Ferrajoli, Alessandra Jain, Nitin George, Binsah James, Danelle Kantarjian, Hagop Burger, Jan O’Brien, Susan |
|---|---|
| author |
Jain, Preetesh Keating, Michael Wierda, William Estrov, Zeev Ferrajoli, Alessandra Jain, Nitin George, Binsah James, Danelle Kantarjian, Hagop Burger, Jan O’Brien, Susan |
| spellingShingle |
Jain, Preetesh Keating, Michael Wierda, William Estrov, Zeev Ferrajoli, Alessandra Jain, Nitin George, Binsah James, Danelle Kantarjian, Hagop Burger, Jan O’Brien, Susan Blood Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib Cell Biology Hematology Immunology Biochemistry |
| author_sort |
jain, preetesh |
| spelling |
Jain, Preetesh Keating, Michael Wierda, William Estrov, Zeev Ferrajoli, Alessandra Jain, Nitin George, Binsah James, Danelle Kantarjian, Hagop Burger, Jan O’Brien, Susan 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2014-09-603670 <jats:title>Key Points</jats:title> <jats:p>Clinical characteristics, causes of discontinuation, and outcome of patients who progress or fail ibrutinib are described. Patients with CLL who progress early on ibrutinib therapy have poor outcomes.</jats:p> Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib Blood |
| doi_str_mv |
10.1182/blood-2014-09-603670 |
| facet_avail |
Online Free |
| finc_class_facet |
Biologie Medizin Chemie und Pharmazie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE0LTA5LTYwMzY3MA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE0LTA5LTYwMzY3MA |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 |
| imprint |
American Society of Hematology, 2015 |
| imprint_str_mv |
American Society of Hematology, 2015 |
| issn |
0006-4971 1528-0020 |
| issn_str_mv |
0006-4971 1528-0020 |
| language |
English |
| mega_collection |
American Society of Hematology (CrossRef) |
| match_str |
jain2015outcomesofpatientswithchroniclymphocyticleukemiaafterdiscontinuingibrutinib |
| publishDateSort |
2015 |
| publisher |
American Society of Hematology |
| recordtype |
ai |
| record_format |
ai |
| series |
Blood |
| source_id |
49 |
| title |
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_unstemmed |
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_full |
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_fullStr |
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_full_unstemmed |
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_short |
Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_sort |
outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| topic |
Cell Biology Hematology Immunology Biochemistry |
| url |
http://dx.doi.org/10.1182/blood-2014-09-603670 |
| publishDate |
2015 |
| physical |
2062-2067 |
| description |
<jats:title>Key Points</jats:title>
<jats:p>Clinical characteristics, causes of discontinuation, and outcome of patients who progress or fail ibrutinib are described. Patients with CLL who progress early on ibrutinib therapy have poor outcomes.</jats:p> |
| container_issue |
13 |
| container_start_page |
2062 |
| container_title |
Blood |
| container_volume |
125 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792348191691112451 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T18:07:16.45Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Outcomes+of+patients+with+chronic+lymphocytic+leukemia+after+discontinuing+ibrutinib&rft.date=2015-03-26&genre=article&issn=1528-0020&volume=125&issue=13&spage=2062&epage=2067&pages=2062-2067&jtitle=Blood&atitle=Outcomes+of+patients+with+chronic+lymphocytic+leukemia+after+discontinuing+ibrutinib&aulast=O%E2%80%99Brien&aufirst=Susan&rft_id=info%3Adoi%2F10.1182%2Fblood-2014-09-603670&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792348191691112451 |
| author | Jain, Preetesh, Keating, Michael, Wierda, William, Estrov, Zeev, Ferrajoli, Alessandra, Jain, Nitin, George, Binsah, James, Danelle, Kantarjian, Hagop, Burger, Jan, O’Brien, Susan |
| author_facet | Jain, Preetesh, Keating, Michael, Wierda, William, Estrov, Zeev, Ferrajoli, Alessandra, Jain, Nitin, George, Binsah, James, Danelle, Kantarjian, Hagop, Burger, Jan, O’Brien, Susan, Jain, Preetesh, Keating, Michael, Wierda, William, Estrov, Zeev, Ferrajoli, Alessandra, Jain, Nitin, George, Binsah, James, Danelle, Kantarjian, Hagop, Burger, Jan, O’Brien, Susan |
| author_sort | jain, preetesh |
| container_issue | 13 |
| container_start_page | 2062 |
| container_title | Blood |
| container_volume | 125 |
| description | <jats:title>Key Points</jats:title> <jats:p>Clinical characteristics, causes of discontinuation, and outcome of patients who progress or fail ibrutinib are described. Patients with CLL who progress early on ibrutinib therapy have poor outcomes.</jats:p> |
| doi_str_mv | 10.1182/blood-2014-09-603670 |
| facet_avail | Online, Free |
| finc_class_facet | Biologie, Medizin, Chemie und Pharmazie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Mi9ibG9vZC0yMDE0LTA5LTYwMzY3MA |
| imprint | American Society of Hematology, 2015 |
| imprint_str_mv | American Society of Hematology, 2015 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229 |
| issn | 0006-4971, 1528-0020 |
| issn_str_mv | 0006-4971, 1528-0020 |
| language | English |
| last_indexed | 2024-03-01T18:07:16.45Z |
| match_str | jain2015outcomesofpatientswithchroniclymphocyticleukemiaafterdiscontinuingibrutinib |
| mega_collection | American Society of Hematology (CrossRef) |
| physical | 2062-2067 |
| publishDate | 2015 |
| publishDateSort | 2015 |
| publisher | American Society of Hematology |
| record_format | ai |
| recordtype | ai |
| series | Blood |
| source_id | 49 |
| spelling | Jain, Preetesh Keating, Michael Wierda, William Estrov, Zeev Ferrajoli, Alessandra Jain, Nitin George, Binsah James, Danelle Kantarjian, Hagop Burger, Jan O’Brien, Susan 0006-4971 1528-0020 American Society of Hematology Cell Biology Hematology Immunology Biochemistry http://dx.doi.org/10.1182/blood-2014-09-603670 <jats:title>Key Points</jats:title> <jats:p>Clinical characteristics, causes of discontinuation, and outcome of patients who progress or fail ibrutinib are described. Patients with CLL who progress early on ibrutinib therapy have poor outcomes.</jats:p> Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib Blood |
| spellingShingle | Jain, Preetesh, Keating, Michael, Wierda, William, Estrov, Zeev, Ferrajoli, Alessandra, Jain, Nitin, George, Binsah, James, Danelle, Kantarjian, Hagop, Burger, Jan, O’Brien, Susan, Blood, Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib, Cell Biology, Hematology, Immunology, Biochemistry |
| title | Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_full | Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_fullStr | Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_full_unstemmed | Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_short | Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_sort | outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| title_unstemmed | Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib |
| topic | Cell Biology, Hematology, Immunology, Biochemistry |
| url | http://dx.doi.org/10.1182/blood-2014-09-603670 |